Overview of Sinartrol
This section provides a foundational overview of the medicinal entity Sinartrol, identifying its composition, type, class, and general purpose.
| Property | Description |
|---|---|
| Active Ingredient | Piroxicam |
| Form | Systemic (Tablets, Capsules) and Topical (Gel, Cream) |
| Pharmacological Class | Nonsteroidal Anti-inflammatory Drug (NSAID) |
| General Purpose | Symptomatic relief of pain and inflammation |
| Origin | Synthetic, Oxicam family derivative |
What Type of Medicine is Sinartrol (Piroxicam)?
Sinartrol is a trade name for a synthetic medicinal entity whose active substance is Piroxicam, classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). Piroxicam chemically belongs to the Oxicam family of enolic acid derivatives, establishing its pharmacological relationship with similar long-acting anti-inflammatory compounds. This classification confirms the drug's core action, which is to mitigate the swelling and pain associated with various musculoskeletal conditions, a utility that is clinically recognized across global formularies. Piroxicam is one of the standard drugs used globally for treating inflammatory symptoms, reinforcing that the medication is a recognized tool for managing discomfort related to inflammation.
Composition and Available Pharmaceutical Forms
The composition of the medicine relies solely on the active ingredient Piroxicam, a compound known for its relatively long duration of action compared to many other NSAIDs. For systemic absorption through the digestive tract, Piroxicam is available in oral dosage forms, specifically capsules or tablets. Conversely, for localized symptomatic management, the compound is integrated into topical preparations, such as gels or creams. The availability of both systemic forms, which use solid oral vehicles, and localized forms, which often use aqueous or hydroalcoholic vehicles, allows for tailored application depending on the condition being managed, such as localized joint discomfort.
General Purpose and Fundamental Action
The general purpose of the medicine is to provide effective symptomatic relief by targeting and reducing the body's inflammatory response. It achieves this fundamental therapeutic effect by acting as a cyclooxygenase inhibitor, a core mechanism shared by its drug class. This action interrupts the process that synthesizes prostaglandins, which are chemical mediators responsible for propagating pain, swelling, and redness in tissues. The primary effect of this drug class is to control the pain and inflammation caused by prostaglandin overproduction. This means the medication works directly to reduce the chemical signals that contribute to pain and swelling.
